Showing results (351-360 of 660) with videos related to
Sort By:
Pageof 66
HIV/AIDS (Auckland, N.Z.)|June 7, 2018
HIV-associated nephropathy: links, risks and managementLaura Palau, Steven Menez, Javier Rodriguez-Sanchez, et al.HIV/AIDS (Auckland, N.Z.)|April 20, 2018
Perceptions of alcohol use in the context of HIV treatment: a qualitative studyMunyaradzi Madhombiro, Bazondlile Marimbe-Dube, Michelle Dube, et al.HIV/AIDS (Auckland, N.Z.)|February 21, 2012
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settingsJanice Soo Fern Lee, Alexandra Calmy, Isabelle Andrieux-Meyer, et al.HIV/AIDS (Auckland, N.Z.)|January 24, 2012
True story about HIV: theory of viral sequestration and reserve infectionSimon Situma BarasaHIV/AIDS (Auckland, N.Z.)|November 19, 2011
Profile of darunavir in the management of treatment-experienced HIV patientsCameron Wolfe, Charles HicksHIV/AIDS (Auckland, N.Z.)|November 19, 2011
Role of darunavir in the management of HIV infectionR Monica Lascar, Paul BennHIV/AIDS (Auckland, N.Z.)|November 19, 2011
Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancyCarmen D Zorrilla, Vivian Tamayo-AgraitHIV/AIDS (Auckland, N.Z.)|November 19, 2011
The prevalence of human immunodeficiency virus infection among TB patients in Port Harcourt NigeriaO Erhabor, Z A Jeremiah, T C Adias, et al.HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Effect of once-daily FDC treatment era on initiation of cARTDavid M Mosen, Michael Horberg, Douglas Roblin, et al.HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maravirocEva Poveda, Vincent SorianoPageof 66